Submitted by Anonymous (not verified) on 19 August 2025 - 13:40
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 18, Status: Authorised